Wellumio
PrivateLast Round
Early Funding
Jul 24, 2026
Est. Valuation
$27.75M
Total Funding Raised
$28.14M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Wellumio operates in Healthcare & Life Sciences and is based in Wellington. Its latest recorded funding round was an Early Funding round in July 2026.
Wellumio is a medical technology company that develops Axana, a portable, AI-enhanced magnetic resonance-based imaging device designed for the rapid diagnosis of acute stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wellumio Comparables
Compare Wellumio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emvision Medical Devices | 81% | |
| Hyperfine | 81% | |
| Chipiron | 80% |
For institutional investors. Book with your work email.
Wellumio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 24, 2026 | ||||
| Early Funding | Jul 24, 2026 | ||||
| Pre Seed | Nov 2, 2025 | ||||
| Grant | Dec 13, 2023 | ||||
| Seed | Jun 1, 2023 | ||||
Grant | Sep 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wellumio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Icehouse Ventures | Early Funding, Seed, Pre Seed |
| Active Investor Plus (AIP) Program | Early Funding |
| Ministry of Business, Innovation and Employment | Grant |
| Snowball Effect | Early Funding |
| Bioshore Capital Partners | Early Funding |
| Outset Ventures | Pre Seed, Seed |
| Bridgewest Venture Fund | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 114% MoM, reaching 1.6K.
- Aug 26, 2026
Grew 31% QoQ, from 16 to 21 employees.
For institutional investors. Book with your work email.
Wellumio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wellumio's valuation, stock price, and market status.
Is Wellumio a public or private company?
Wellumio is a private company.
What is the current stock price of Wellumio?
Wellumio is a private company, so its shares have no public market price. Caplight tracks Wellumio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wellumio worth (valuation)?
Wellumio's valuation is estimated at $27.8M based on funding round data.
Can I buy Wellumio stock?
Wellumio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wellumio's last funding round?
Wellumio's most recent funding round was Early Funding on July 24, 2026.
Who are the main investors in Wellumio?
Key investors in Wellumio include Outset Ventures, Nuance Connected Capital.
Will Wellumio IPO soon?
No public IPO plans have been announced for Wellumio.
How can I track Wellumio secondary market activity?
Caplight tracks bids, offers, and trades in Wellumio's shares on secondary markets.